Scorpion Venom Active Polypeptide May Be a New External Drug of Diabetic Ulcer

Overview

Journal Evid Based Complement Alternat Med

Specialty Rehabilitation Medicine

Date 2017 Dec 14

PMID 29234410

Citations 3

Authors

Ting Wan

Luocheng Li

Zhanyong Zhu

Siyang Liu

Yueqiang Zhao

Mosheng Yu

Affiliations

Soon will be listed here.

Abstract

Background: The epidermal growth factor (EGF) is recognized medicine of therapy in ulcer. However, its efficacy has been challenged. We compared scorpion venom active polypeptide and EGF of therapeutic effects in diabetic ulcer.

Methods: The scorpion venom active polypeptide is made into gel. Fourteen diabetic SD rats were randomly divided into scorpion peptide gel group (SPG group) and EGF group. Before treatment, the rat model of diabetic ulcer was created. The levels of IL-1, IL-6, IL-8, and TNF- in the wound tissue were measured at different time points during the treatment, secretions of wound were collected for bacterial culture, and the wound healing was recorded.

Results: Wound healing was faster in SPG group compared to EGF group (3 weeks versus 5 weeks, -test, = 0.032). The levels of IL-1, IL-6, IL-8, and TNF- were not statistically different when the wounds were formed but showed significant differences from the 2nd to the 5th week between two groups. The infection rate was higher in the EGF group (42.86% versus 0, Chi-square test, = 0.025).

Conclusions: Scorpion venom active polypeptide shortens wound healing with a stronger anti-inflammation and antibacterial effect and may be a new and effective topical drug for the treatment of diabetic ulcers.

Citing Articles

Current Insight of Peptide-Based Hydrogels for Chronic Wound Healing Applications: A Concise Review.

Nizam A, Masri S, Fadilah N, Maarof M, Fauzi M Pharmaceuticals (Basel). 2025; 18(1).

PMID: 39861121 PMC: 11768948. DOI: 10.3390/ph18010058.

The Promoting Effect of Animal Bioactive Proteins and Peptide Components on Wound Healing: A Review.

Fan X, Ye J, Zhong W, Shen H, Li H, Liu Z Int J Mol Sci. 2024; 25(23).

PMID: 39684273 PMC: 11640812. DOI: 10.3390/ijms252312561.

Scorpion Venom Polypeptide Inhibits Pulmonary Epithelial-Mesenchymal Transition in Systemic Sclerosis-Interstitial Lung Disease Model Mice by Intervening TGF-1/Smad Signaling Pathway.

Zhang Y, Xu L, Chen Q, Guan T, Lin N, Xu D Evid Based Complement Alternat Med. 2022; 2022:6557486.

PMID: 35463079 PMC: 9020946. DOI: 10.1155/2022/6557486.

Antiinflammatory peptides: current knowledge and promising prospects.

Dadar M, Shahali Y, Chakraborty S, Prasad M, Tahoori F, Tiwari R Inflamm Res. 2018; 68(2):125-145.

PMID: 30560372 DOI: 10.1007/s00011-018-1208-x.

References

Fjell C, Hancock R, Cherkasov A . AMPer: a database and an automated discovery tool for antimicrobial peptides. Bioinformatics. 2007; 23(9):1148-55. DOI: 10.1093/bioinformatics/btm068. View

Dai L, Yasuda A, Naoki H, Corzo G, Andriantsiferana M, Nakajima T . IsCT, a novel cytotoxic linear peptide from scorpion Opisthacanthus madagascariensis. Biochem Biophys Res Commun. 2001; 286(4):820-5. DOI: 10.1006/bbrc.2001.5472. View

Ertugrul B, Lipsky B, Guvenc U . An Assessment of Intralesional Epidermal Growth Factor for Treating Diabetic Foot Wounds. J Am Podiatr Med Assoc. 2017; 107(1):17-29. DOI: 10.7547/15-056. View

Zucchi P, Ferrari P, Spina M . [Diabetic foot: from diagnosis to therapy]. G Ital Nefrol. 2005; 22 Suppl 31:S20-2. View

Torres-Larios A, Gurrola G, Zamudio F, Possani L . Hadrurin, a new antimicrobial peptide from the venom of the scorpion Hadrurus aztecus. Eur J Biochem. 2000; 267(16):5023-31. DOI: 10.1046/j.1432-1327.2000.01556.x. View

Danigo A, Nasser M, Bessaguet F, Javellaud J, Oudart N, Achard J . Candesartan restores pressure-induced vasodilation and prevents skin pressure ulcer formation in diabetic mice. Cardiovasc Diabetol. 2015; 14:26. PMC: 4394592. DOI: 10.1186/s12933-015-0185-4. View

Jenssen H, Hamill P, Hancock R . Peptide antimicrobial agents. Clin Microbiol Rev. 2006; 19(3):491-511. PMC: 1539102. DOI: 10.1128/CMR.00056-05. View

Dai C, Ma Y, Zhao Z, Zhao R, Wang Q, Wu Y . Mucroporin, the first cationic host defense peptide from the venom of Lychas mucronatus. Antimicrob Agents Chemother. 2008; 52(11):3967-72. PMC: 2573117. DOI: 10.1128/AAC.00542-08. View

Xu S, Liang T . Clinical observation of the application of autologous peripheral blood stem cell transplantation for the treatment of diabetic foot gangrene. Exp Ther Med. 2016; 11(1):283-288. PMC: 4727100. DOI: 10.3892/etm.2015.2888. View

10.

Kumar M, Gautam M, Singh A, Goel R . Healing effects of Musa sapientum var. paradisiaca in diabetic rats with co-occurring gastric ulcer: cytokines and growth factor by PCR amplification. BMC Complement Altern Med. 2013; 13:305. PMC: 3826524. DOI: 10.1186/1472-6882-13-305. View

11.

Moerman L, Bosteels S, Noppe W, Willems J, Clynen E, Schoofs L . Antibacterial and antifungal properties of alpha-helical, cationic peptides in the venom of scorpions from southern Africa. Eur J Biochem. 2002; 269(19):4799-810. DOI: 10.1046/j.1432-1033.2002.03177.x. View

12.

Bea R, Petraglia A, Ascuitto M, Buck Q . Antibacterial Activity and Toxicity of Analogs of Scorpion Venom IsCT Peptides. Antibiotics (Basel). 2017; 6(3). PMC: 5617977. DOI: 10.3390/antibiotics6030013. View

13.

Karakas A, Arslan E, Cakmak T, Aydin I, Akgul E, Demirbas S . Predictive Value of Soluble CD14, Interleukin-6 and Procalcitonin For Lower Extremity Amputation in People with Diabetes with Foot Ulcers: A Pilot Study. Pak J Med Sci. 2014; 30(3):578-82. PMC: 4048510. DOI: 10.12669/pjms.303.4575. View

14.

Borchani L, Sassi A, Ben Gharsa H, Safra I, Shahbazzadeh D, Ben Lasfar Z . The pathological effects of Heminecrolysin, a dermonecrotic toxin from Hemiscorpius lepturus scorpion venom are mediated through its lysophospholipase D activity. Toxicon. 2013; 68:30-9. DOI: 10.1016/j.toxicon.2013.03.012. View

15.

Zhao Z, Ma Y, Dai C, Zhao R, Li S, Wu Y . Imcroporin, a new cationic antimicrobial peptide from the venom of the scorpion Isometrus maculates. Antimicrob Agents Chemother. 2009; 53(8):3472-7. PMC: 2715652. DOI: 10.1128/AAC.01436-08. View

16.

Conde R, Zamudio F, Rodriguez M, Possani L . Scorpine, an anti-malaria and anti-bacterial agent purified from scorpion venom. FEBS Lett. 2000; 471(2-3):165-8. DOI: 10.1016/s0014-5793(00)01384-3. View

17.

Hong J, Choi S, Li K, Kim B . Skin necrosis after filler-associated vascular compromise: successful treatment with topical epidermal growth factor. Int Wound J. 2016; 14(3):587-588. PMC: 7949755. DOI: 10.1111/iwj.12685. View

18.

Chen J, Jin J, Song M, Dong H, Zhao G, Huang L . C-reactive protein down-regulates endothelial nitric oxide synthase expression and promotes apoptosis in endothelial progenitor cells through receptor for advanced glycation end-products. Gene. 2012; 496(2):128-35. DOI: 10.1016/j.gene.2011.12.039. View

19.

Brem H, Tomic-Canic M . Cellular and molecular basis of wound healing in diabetes. J Clin Invest. 2007; 117(5):1219-22. PMC: 1857239. DOI: 10.1172/JCI32169. View

20.

Uccioli L, Izzo V, Meloni M, Vainieri E, Ruotolo V, Giurato L . Non-healing foot ulcers in diabetic patients: general and local interfering conditions and management options with advanced wound dressings. J Wound Care. 2015; 24(4 Suppl):35-42. DOI: 10.12968/jowc.2015.24.Sup4b.35. View